Hims & Hers adds Dr. Andrew Huberman to board; signs $3.5M advisory and $5M podcast deals

Hims & Hers Health, Inc.

Board expanded from nine to ten directors and appointed Dr. Andrew Huberman, 51, effective Nov. 4, 2026; term runs to the 2027 annual meeting.
Huberman is not independent under NYSE standards, has no Board committee assignment, and receives a $50,000 annual cash retainer plus $250,000 annual equity, prorated.
Hims Inc. signed a two-year advisory agreement with Huberman for $3.5M annually, plus up to $1M more per year for optional short-form videos for paid advertising.
Hims also signed a marketing services agreement with Scicomm Media LLC, co-owned by Huberman, for podcast ads up to three years at $5M annually; his interest is about $2.1M per year.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.